Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 4, 2010, Pages 1033-1039

  Burdick, Michael J ^a   Stephans, Kevin L ^a   Reddy, Chandana A ^a   Djemil, Toufik ^a   Srinivas, Shyam M ^a   Videtic, Gregory M M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

FDG; Non small cell lung cancer; Positron emission tomography; Standardized uptake value; Stereotactic body radiotherapy

Indexed keywords

2-DEOXY-2; CONFIDENCE INTERVAL; DISTANT METASTASIS; FDG; FLUORO D GLUCOSE; HAZARD RATIO; IMAGE-GUIDED; LOCAL CONTROL; LOCAL FAILURE; MEDICALLY INOPERABLE; MULTIVARIABLE ANALYSIS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES; PRE-TREATMENT; PROPORTIONAL HAZARDS; STANDARDIZED UPTAKE VALUES; STEREOTACTIC BODY RADIOTHERAPY; TREATMENT OUTCOMES; UNIVARIATE ANALYSIS;

BIOLOGICAL ORGANS; ELECTRONS; FORECASTING; GLUCOSE; PATIENT MONITORING; PESTICIDE EFFECTS; POPULATION STATISTICS; POSITRONS; RADIOTHERAPY;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME; TUMOR BIOPSY; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; LUNG; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RADIATION DOSE; RADIOSURGERY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SCINTISCANNING; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOSURGERY; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77958459036     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.09.081     Document Type: Article

References (35)

1. M. Hatanaka Transport of sugars in tumor cell membranes Biochimica et Biophysica Acta 355 1974 77 104
2. O. Warburg On the origin of cancer cells Science 123 1956 309 314
3. N.C. Gupta, A.R. Frank, and N.A. Dewan Solitary pulmonary nodules: Detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose Radiology 184 1992 441 444
4. K. Kubota, T. Matsuzawa, and T. Fujiwara Differential diagnosis of lung tumor with positron emission tomography: A prospective study J Nucl Med 31 1990 1927 1932
5. J. Bradley, W.L. Thorstad, and S. Mutic Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 59 2004 78 86
6. A. van Der Wel, S. Nijsten, and M. Hochstenbag Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: A modeling study Int J Radiat Oncol Biol Phys 61 2005 649 655
7. T. Berghmans, M. Dusart, and M. Paesmans Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): A systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project J Thorac Oncol 3 2008 6 12
8. B.K. Chang, and R.D. Timmerman Stereotactic body radiation therapy: A comprehensive review Am J Clin Oncol 30 2007 637 644
9. J.J. Beitler, E.A. Badine, and D. El-Sayah Stereotactic body radiation therapy for nonmetastatic lung cancer: An analysis of 75 patients treated over 5 years Int J Radiat Oncol Biol Phys 65 2006 100 106
10. H. Onishi, T. Araki, and H. Shirato Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study Cancer 101 2004 1623 1631
11. H. Vesselle, R.A. Schmidt, and J.M. Pugsley Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography Clin Cancer Res 6 2000 3837 3844
12. H. Vesselle, A. Salskov, and E. Turcotte Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index J Thorac Oncol 3 2008 971 978
13. N. Fuwa, T. Mitsudomi, and T. Daimon Factors involved in lymph node metastasis in clinical stage I non-small cell lung cancer - from studies of 604 surgical cases Lung Cancer 57 2007 311 316
14. F.L. Greene American Joint Committee on Cancer, American Cancer Society AJCC cancer staging manual 6th ed 2002 Springer-Verlag New York
15. G.M. Videtic, T.W. Rice, and S. Murthy Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: Insights for radiotherapy planning from a surgical cohort Int J Radiat Oncol Biol Phys 72 2008 702 706
16. M. Uematsu, A. Shioda, and A. Suda Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience Int J Radiat Oncol Biol Phys 51 2001 666 670
17. Radiation Therapy Oncology Group. Radiation Therapy Oncology Group 0236 protocol. Available at: http://wwwrtog.org/members/protocols/0236/0236pdf. Accessed July 1, 2009.
18. G.M. Videtic, K. Stephans, and C. Reddy Intensity-Modulated Radiotherapy-Based Stereotactic Body Radiotherapy for Medically Inoperable Early-Stage Lung Cancer: Excellent Local Control Int J Radiat Oncol Biol Phys 2009 Sep 16 [Epub ahead of print]
19. M.S. Pepe, and M. Mori Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12 1993 737 751
20. F.C. Detterbeck, J.F. Vansteenkiste, and D.E. Morris Seeking a home for a PET, part 3: Emerging applications of positron emission tomography imaging in the management of patients with lung cancer Chest 126 2004 1656 1666
21. T. Fujisawa, T. Iizasa, and Y. Saitoh Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas J Clin Oncol 17 1999 2086 2091
22. H. Kawai, A. Tada, and M. Kawahara Smoking history before surgery and prognosis in patients with stage IA non-small-cell lung cancer - a multicenter study Lung Cancer 49 2005 63 70
23. K. Higashi, Y. Ueda, and Y. Arisaka 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer J Nucl Med 43 2002 39 45
24. B. Goodgame, G.A. Pillot, and Z. Yang Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer J Thorac Oncol 3 2008 130 134
25. T. Ohtsuka, H. Nomori, and K. Watanabe Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma Cancer 107 2006 2468 2473
26. W.K. de Jong, H.F. van der Heijden, and J. Pruim Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: A two-center study J Thorac Oncol 2 2007 1007 1012
27. D.J. Hoopes, M. Tann, and J.W. Fletcher FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer Lung Cancer 56 2007 229 234
28. X. Qiao, O. Tullgren, and I. Lax The role of radiotherapy in treatment of stage I non-small cell lung cancer Lung Cancer 41 2003 1 11
29. E.J. Hall, and A.J. Giaccia Radiobiology for the radiologist 6th ed. 2006 Lippincott Williams & Wilkins Philadelphia
30. C.F.D.G. Franzius PET: Advantages for staging the mediastinum? Lung Cancer 45 Suppl. 2 2004 S69 S74
31. P.C. Lee, J.L. Port, and R.J. Korst Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer Ann Thorac Surg 84 2007 177 181
32. L. Trodella, P. Granone, and S. Valente Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: Definitive results of a phase III randomized trial Radiother Oncol 62 2002 11 19
33. H. Kato, Y. Ichinose, and M. Ohta A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung N Engl J Med 350 2004 1713 1721
34. R.J. Ginsberg, and L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 60 1995 615 622 discussion 22-3
35. Z.J. Zhang, J.H. Chen, and L. Meng 18F-FDG uptake as a biologic factor predicting outcome in patients with resected non-small-cell lung cancer Chin Med J 120 2007 125 131